Ufundisiso lwaqhutywa eRomania
- Uphononongo lwenziwe yiMedLife Medical System, inkokeli kumayeza abucala eRomania, kwaye yayijonge ukuvavanya inqanaba logonyo olufunyenwe ngokwemvelo okanye lulandela ugonyo eRomania, kwinqanaba ledolophu.
- Ngokoogqirha be-MedLife, inqanaba lokugonywa komhlambi kwinqanaba ledolophu lingaphezulu kwe-60% yabemi, okt phakathi kwe-6 kunye ne-7 yezigidi zabemi, kuphela kwizixeko ezimele i-54% yabemi baseRomania.
- Ukuba indawo yasemaphandleni yayithathelwe ingqalelo, inani labo bafumene isifo okanye bagonywe banokufikelela kwi-10-12 yezigidi zabantu.
- Ngaphantsi kwe-10% yabo bafumene isifo kodwa abazange bagonywe babonisa i-titres yokuthobisa izilwa-buhlungu.[1]
- I-Romania inokuba yeyona ndawo ibalulekileyo ye-nursery iYurophu kutyalo-mali nokhenketho. Oku, nangona kunjalo, kuxhomekeke kukwanda okukhawulezileyo kumazinga ogonyo.
Ngokubandakanyeka kwimisebenzi yophando ukusukela ekuqaleni kobhubhane, iMedLife Medical System, njengenkokeli yoshishino eRomania, yenze uphononongo olutsha, ngecandelo layo lophando, ukuvavanya inqanaba logonyo olufunyenwe ngokwendalo okanye lulandela ugonyo eRomania, ezidolophini. inqanaba. Uphando olunjalo lwenziwe kwisampulu emele abantu abangama-943, abahlali kwizixeko ezineempawu ezahlukeneyo ngokwenqanaba lokugonywa kunye nenqanaba losulelo: Bucharest, Cluj, Constanța, Timișoara - Zone 1, kunye neGiurgiu, Suceava kunye nePiatra Neamț - Zone 2, ngokulandelelanayo. .
Ukumisela i-antibody titre ngokuchasene ne-COVID-19, i-RBD IgG (iqhekeza leprotein) uvavanyo lwe-serological kwiprotein ye-spike lwenziwa kusetyenziswa iinkqubo zohlalutyo ze-Abbott, ezilinganisa ngokobungakanani inqanaba le-antibodies kunye ne-SARS-CoV-2 Antibody (IgG) umgangatho we-nucleocapsid. iimvavanyo eziqinisekisa okanye eziphikisa ubukho be-antibodies.
"Senza uluntu iziphumo zendlela entsha yophando eqhutywe ngokupheleleyo kwimithombo yethu kwaye ngokukodwa oogqirha baseRomania kunye neengcali. Idatha ibonisa ukuba inqanaba lokugonywa komhlambi kuphela kwinqanaba ledolophu, eRomania, lingaphezulu kwe-60%, oko kukuthi i-6-7 yezigidi zaseRomania, ebonisa inkqubela phambili enkulu yezinga lokugonywa, njengoko ngoMeyi kulo nyaka uphelileyo thina, iMedLife, ebhengeza, okokuqala, ukuba ukungakhuseleki kwabantu baseRomania kwi-COVID-19 bekungaphantsi kwe-2%. Ngaphezu koko, ukuba sikhupha idatha kwaye sithathela ingqalelo indawo yasemaphandleni, mhlawumbi sithetha malunga ne-10-12 yezigidi zabantu baseRomania abafumana isifo okanye bagonywa.. Noko ke, eli asiloxesha lokuphumla. Uphononongo kuhlobo lweDelta lubonisa ngaphandle kwamathandabuzo ukuba ukhuselo lwendalo, olufumaneka emva kokufumana isifo, alusebenzi ngokuchasene nohlobo olutsha lweDelta. I-Wave 4 isondele kunokuba bekucingelwa ekuqaleni, mhlawumbi kwinyanga kwiRomania uninzi luya kuphinda lunamawaka eemeko ngosuku ngenxa yolu hlobo losulelo ngakumbi.
Kukho isisombululo esinye kuphela: lokugonywa. Ukuba inqanaba eliphezulu logonyo lwendalo belikhatshwa lizinga eliphezulu ngokulinganayo logonyo olufunyenwe ngogonyo, iRomania ngeyenze kakuhle kakhulu kwinqanaba laseYurophu. Iphulo lokugonya libonakalise ukuba lilungelelaniswe ngokugqwesileyo kwilizwe lethu, ngokugubungela umhlaba olungileyo kakhulu kunye nokufumaneka kwesitokhwe sokugonya, kodwa ukwanda okumandla ngakumbi kunxibelelwano kuyafuneka ukwazisa uluntu ngokubaluleka kwesi siganeko kunye nokunyusa amazinga ogonyo njengoko. ngokukhawuleza kangangoko kunokwenzeka. Ukuba sibeka phambili ugonyo kwixesha elizayo, sinethuba lokuba yeyona ndawo ibalulekileyo yaseYurophu kutyalo-mali nakukhenketho”, utshilo uMihai Marcu, uMongameli kunye ne-CEO yeMedLife Group.
Abantu abaphindwe kathathu kwizixeko ezikhulu zaseRomania bosulelwe yintsholongwane ye-SARS-CoV-2 xa kuthelekiswa neengxelo ezisemthethweni. Kwizixeko ezincinci, amanani akhula ngendlela eyothusayo
Uphononongo olwenziwe ziingcali ze-MedLife lubonisa ukuba abantu abaphindwe kathathu kwizixeko ezikhulu zaseRomania bosulelwe yintsholongwane ye-SARS-CoV-2, xa kuthelekiswa neengxelo ezisemthethweni ezibonisa kuphela inani labantu abafumene esi sifo kwaye bathatha uvavanyo lwe-PCR. qinisekisa ukuxilongwa. Ke ngoko, ngokovavanyo lwe-serological olwenziwa ngexesha lendlela eyenziwa yi-MedLife, i-34% yabemi abafundwe kwizixeko ezikhulu baye bachanabeka kusulelo lwe-COVID-19 ukusukela oko kwaqala ubhubhane ukuya phambili. Kwezi, ngaphezu kwesiqingatha kusenokwenzeka ukuba azibonakalisi. Ngaphezu koko, olu phononongo lunye lubonisa ukuba i-50% yabemi beedolophu ezincinci bafumana esi sifo, ukuya kuthi ga kwizihlandlo ezilithoba ngaphezulu kwamanani achazwe ngokusemthethweni.
Nangona kunjalo, imeko ihleli ixhalabile eRomania, kuba abantu abafumene esi sifo kwaye abagonywanga banethuba elihle lokuphinda bosulelwe ziintlobo ezintsha ze-coronavirus ezisasazwayo. Kwakhona, ngokungafaniyo namazwe aseNtshona Yurophu, abantu abaneminyaka engaphezu kwama-60, abona bantu bachanabeka kwiintlobo ezinzima zesi sifo, kuquka ukulaliswa esibhedlele kunye nokufa, bakhethe ukugonywa kancinane.
Ngaphandle kwesantya sokugonywa komhlambi, iRomania isekude nokuphela kobhubhane
Nangona idatha yezinga lokugonywa komhlambi inethemba, iqela lophando leMedLife lilumkisa ukuba iliza lesine lobhubhane alinakuphepheka kwaye iziphumo zalo kwinkqubo yezempilo yaseRomania kunye noqoqosho luya kuba buhlungu ukuba izinga lokugonya alinyuki ngokukhawuleza kwithuba elilandelayo.
Oku kuchazwa yinto yokuba ngaphantsi kwe-10% yabo badibana nentsholongwane, kodwa abazange bagonywe, bane-antibody titre engathathi hlangothi. Nangona kunjalo, oogqirha be-MedLife bachaza ukuba isiphumo sogonyo kunye nembali ye-COVID-19 yomelele kakhulu, nge-84% yabo bafumana esi sifo kwaye bagonywa ukuba bane-antibody titre, kubandakanya noxinzelelo lweDelta.
"Izinga eliphezulu lokungakhuseleki komhlambi kwinqanaba ledolophu lingasinika umbono wokuba imeko iphantsi kolawulo, kodwa, ngelishwa, sisekude nokuphelisa lo bhubhani. Sele sisazi ukuba kwimeko yezigulana ezingabonakaliyo okanye abantu abaneendlela ezithambileyo zesi sifo, inani labo bangakhange baphuhlise izilwa-buhlungu kwaphela ngenxa yokunxibelelana nentsholongwane, okanye baphuhlise i-antibody titre ephantsi kakhulu xa kuthelekiswa nayo. abo babeneentlobo ezinzima zesifo. Ke ngoko, kukho ukuguquguquka kwempendulo yokhuselo lomzimba kusulelo lwentsholongwane, ngakumbi xa kufikwa kwiintlobo ezintsha, ezinje ngoxinzelelo lweDelta, olukhula ngamandla kwilizwe lethu kwaye oluya kuthi lube lukhulu kwixesha elizayo. Ngoko ke, kulo mzuzu, ukugonywa yindlela yodwa yokuzikhusela kule ntsholongwane, kwaye ukuba asinyusi izinga lokugonywa, mhlawumbi, ekwindla, izibhedlele zaseRomania ziya kuqala ukujongana nemiphumo yeli wave lesine. yobhubhane“, utshilo uDumitru Jardan, isazi ngebhayoloji kwicandelo lophando leMedLife Group.
Ubungqina bokuba umsebenzi wokugonya unikezelwa lelona komkhulu laseRomania, iBucharest, ebonakala inelona zinga liphezulu logonyo elizweni. Idatha ehlalutyiweyo ibonisa ukuba phantse i-70% yabo bonke abahlali baseBucharest bafumene ukungakhuseleki kwi-COVID-19 ngokwendalo okanye ngogonyo, kwaye oku kunxulunyaniswa nezinga eliphezulu lokugonya elirekhodwe eBucharest.
IMedLife, ekuphela kwenkampani yabucala yezonyango eRomania etyale imali ebalulekileyo kuphando kwaye yakwazi ukujonga ubhubhane ngegalelo elibalulekileyo kuluntu.
Njengeyona nkampani inkulu yabucala yezonyango eRomania kwaye iyona kuphela enokhuselo lwelizwe, iMedLife ibizikhathaza ngempilo yoluntu kwaye ithathe inxaxheba ngokukhutheleyo kuqwalaselo lobhubhane, iqhuba izifundo ezibanzi noogqirha baseRomania, iingcali zebhayoloji kunye nabaphandi. Ukusukela kwiinyanga zokuqala zobhubhane, inkampani yagxila kwiinzame kunye nezixhobo zokubeka iliso kwinkqubela phambili yesifo esibulalayo elizweni, kwaye ibe negalelo elikhulu ekwaziseni abantu kunye nabasemagunyeni eRomania.
Ngapha koko, inkampani kungoku nje isebenza kuphononongo lokuqala kulo mmandla oluvavanya impendulo yokhuselo lomzimba ngokuchasene ne-COVID-19, kwaye kungekudala iza kubuya nolwazi olubalulekileyo lwenkqubela-phambili yobhubhane ngokumalunga nokuxhathisa kwabo basifumene esi sifo. usulelo olutsha.
***
INkqubo yezoNyango yeMedLife kuphela kwenkqubo yaseRomania enenkxalabo ngempilo yoluntu ukusukela oko kwaqala ubhubhane, eqhube izifundo ezingaphantsi kwe-9 kuphela ngemali kunye nezixhobo zayo, ebandakanya oogqirha kunye nabaphandi baseRomania. Ke, inkampani inike abasemagunyeni ulwazi olubalulekileyo malunga nogonyo lwendalo lwabemi, kwinqanaba lesizwe kunye noqhambuko oluthile, ukuvela kwe-antibodies kwi-COVID-19, imvelaphi yentsholongwane ye-SARS-CoV-2 ejikeleza eRomania, kwaye indlela yosasazo okanye ubukho bezinye iintlobo.
Utyalo-mali lweMedLife kwizenzo zophando lufikelela ngaphezulu kwezigidi ezibini zeeyuro ukusukela oko kwaqala ubhubhane. Inkqubo yophando iqhutywa ngokukodwa kwiimali zenkampani.
Inkampani iyaqhubeka nokutyala imali kuphando, kwaye kungoku nje iqhuba isifundo sokuqala kulo mmandla malunga nokuphendula kwamajoni omzimba ngokuchasene ne-COVID-19, iziphumo eziya kuthi zibaluleke kakhulu ekuveleni kobhubhane.
[1] Amaxabiso>= 3950 AU/ml aye alingana nethuba le-95% kunye ne-neutralization titres> = 1: 250 (PRNT ID50). Iziphumo ezifunyenwe kwamanye amaqonga ohlalutyo azinakuthelekiswa.
